Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401.

Cancers·2026
Same author

Independent Clonal Evolution in Primary Pigmented Nodular Adrenocortical Disease: A Single-Patient Multi-Omics Study.

European journal of endocrinology·2026
Same author

Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET study.

International journal of clinical oncology·2026
Same author

GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer.

EJNMMI research·2026
Same author

Clinical practice guidelines for telesurgery, 2nd Edition : Committee for the Promotion of Remote Surgery Implementation, Japan Surgical Society.

Surgery today·2026
Same author

Reduced Uncoupling Protein 1 Expression in Periprostatic Adipose Tissue and Its Association With Higher Prostate Cancer Grade.

International journal of urology : official journal of the Japanese Urological Association·2026
Same journal

Letter to Editor of Annals of Surgical Oncology Concerning "The Impact of Diagnostic Laparoscopy on Upstaging Patients with Siewert II and III Gastroesophageal Junction (GEJ) Cancer".

Annals of surgical oncology·2026
Same journal

Surgical Safety after Preoperative Chemotherapy for Perihilar Cholangiocarcinoma: Multi-Institutional Propensity-Matched Analysis.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Omission of Axillary Surgery in Patients with Invasive Lobular Carcinoma of the Breast-Rates of Nodal Involvement in Clinically Node-Negative Patients and Impact on Recurrence in a Single-Institution Analysis.

Annals of surgical oncology·2026
Same journal

Resection of Primary Lung Tumors in Patients with Stage IV EGFR-Mutant Lung Adenocarcinoma before Progression under First-Line TKI Treatment and Its Impact on Prognosis.

Annals of surgical oncology·2026
Same journal

Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and Axilla.

Annals of surgical oncology·2026
Same journal

ASO Author Reflections: Atypical Breast Lesions on Core Needle Biopsy: Defining a Low-Risk Population to Guide Selective Surgical Excision.

Annals of surgical oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.8K

Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder Cancer.

Takahiko Hajime1,2, Masaki Shiota3, Genshiro Fukuchi1

  • 1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Annals of Surgical Oncology
|January 16, 2026
PubMed
Summary
This summary is machine-generated.

Bladder cancer tumor location predicts lymph node spread. Laterality guides tailored pelvic lymph node dissection (PLND) to balance efficacy and reduce morbidity.

Keywords:
LateralityLymph node involvementPelvic lymph node dissectionRadical cystectomyTumor location

More Related Videos

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

13.3K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Related Experiment Videos

Last Updated: Jun 30, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.8K
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

13.3K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Area of Science:

  • Urology
  • Surgical Oncology
  • Cancer Research

Background:

  • Lymph node involvement (LNI) is crucial for bladder cancer prognosis and adjuvant therapy decisions.
  • Extended pelvic lymph node dissection (PLND) offers no survival benefit over standard PLND but increases morbidity.
  • Tailoring PLND templates based on tumor characteristics like laterality may optimize risk-benefit.

Purpose of the Study:

  • To investigate the relationship between bladder tumor location (laterality) and lymph node metastasis patterns.
  • To determine if tumor laterality influences the distribution of lymph node involvement in bladder cancer patients.

Main Methods:

  • Retrospective review of 102 patients undergoing radical cystectomy with bilateral extended PLND.
  • Classification of tumor laterality as unilateral or bilateral.
  • Categorization of lymph node sites by laterality (ipsilateral/contralateral) and anatomical level (I and II).

Main Results:

  • Overall LNI rate was 17.6%.
  • Bilateral tumors showed a higher metastasis rate (24.2%) compared to unilateral tumors (14.5%).
  • Contralateral LNI without ipsilateral involvement was rare (1.5%), as was skip metastasis to Level II (1.0%).

Conclusions:

  • Bladder tumor laterality is a significant predictor of lymph node metastasis distribution.
  • The low incidence of contralateral or skip metastasis suggests potential for tailored PLND strategies based on tumor location.
  • Prospective studies are needed to validate tumor location-based PLND approaches.